GLOBAL AUTOIMMUNE POLYGLANDULAR SYNDROME TYPE 1 MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Global Autoimmune Polyglandular Syndrome Type 1 Market, By Diagnosis (Serum Autoimmune Screen, End-organ Function Tests, Blood Tests), By Treatment (Medication, Antifungal Agents, Fluconazole, Itraconazole, Calcitriol, Corticosteroids, Others), By Dosage Form (Tablet, Capsule, Others), By Route of Administration (Oral, Others), By Age of Onset (Childhood, Adult, Adolescent), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Global Autoimmune Polyglandular Syndrome Type 1 Market- Recent Developments

Business Development Activities by the Market Players

On July 7, 2023, the National Organization for Rare Disorders (NORD) and the APS Type 1 Foundation, a NORD member organization, announced the awarding of a US$50,000 grant for research into this rare autoimmune disorder. The grant, which is part of NORD’s Jayne Holtzer Rare Disease Research Grants Program, was made possible by funding from the APS Type 1 Foundation.